Medicare Enrolled
Dr. Marin Xavier, MD
Hematology & Oncology · San Diego, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Xavier from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Xavier?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Xavier
Dr. Marin Xavier is a hematology & oncology specialist in San Diego, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Xavier performed 1,580 Medicare services across 820 unique beneficiaries.
Between the years covered by Open Payments, Dr. Xavier received a total of $933,603 from 100 pharmaceutical and/or device companies across 1798 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Xavier is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 43% volume in CA
$933,603 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,580
Medicare services
Top 43% in CA for hematology & oncology
820
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~83 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
663 | $101 | $350 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
338 | $145 | $491 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
271 | $8 | $27 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
110 | $98 | $269 |
| New patient office visit, complex (60-74 min) | 59 | $169 | $598 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
42 | $33 | $45 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
40 | $72 | $191 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
29 | $143 | $521 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
28 | $104 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$933,603
Total received (2018-2024)
Avg $133,372/year across 7 years
Top 1% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
100
Companies
1,798
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$791,516 (84.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$125,012 (13.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,075 (1.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$111,243
2023
$152,874
2022
$127,165
2021
$101,969
2020
$119,028
2019
$189,951
2018
$131,373
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
BeiGene USA, Inc.
$27,942
Lilly USA, LLC
$18,340
E.R. Squibb & Sons, L.L.C.
$17,361
AstraZeneca Pharmaceuticals LP
$14,644
Genmab U.S., Inc.
$12,403
ABBVIE INC.
$9,810
SOBI, INC
$3,252
Incyte Corporation
$2,418
GlaxoSmithKline, LLC.
$1,757
Celgene Corporation
$911
Novartis Pharmaceuticals Corporation
$267
PFIZER INC.
$213
Eisai Inc.
$190
PharmaEssentia USA Corporation
$189
Alexion Pharmaceuticals, Inc.
$162
Janssen Biotech, Inc.
$137
Regeneron Healthcare Solutions, Inc.
$124
Kite Pharma, Inc.
$79
Genentech, Inc.
$74
ARRAY BIOPHARMA INC
$67
Exelixis Inc.
$65
Rigel Pharmaceuticals, Inc.
$62
Merck Sharp & Dohme LLC
$61
Deciphera Pharmaceuticals Inc.
$60
Coherus Biosciences Inc.
$57
Ipsen Biopharmaceuticals, Inc
$56
Agios Pharmaceuticals, Inc.
$46
Daiichi Sankyo Inc.
$41
TerSera Therapeutics LLC
$38
SERVIER PHARMACEUTICALS LLC
$36
Takeda Pharmaceuticals U.S.A., Inc.
$36
Astellas Pharma US Inc
$35
Gilead Sciences, Inc.
$31
TAIHO ONCOLOGY, INC.
$30
Blueprint Medicines Corporation
$30
PUMA BIOTECHNOLOGY, INC.
$28
ADC Therapeutics America, Inc.
$28
Mirati Therapeutics, Inc.
$28
Geron Corporation
$26
Stemline Therapeutics Inc.
$22
Adaptive Biotechnologies Corporation
$20
Tempus AI, Inc
$20
Bayer Healthcare Pharmaceuticals Inc.
$18
Sumitomo Pharma America, Inc.
$15
GENZYME CORPORATION
$14
Top 3 companies account for 57.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$140,317
Incyte Corporation
$110,496
Celgene Corporation
$99,551
BeiGene USA, Inc.
$78,760
Lilly USA, LLC
$65,035
AbbVie, Inc.
$55,306
E.R. Squibb & Sons, L.L.C.
$40,948
Gilead Sciences, Inc.
$36,406
Genentech USA, Inc.
$36,002
Takeda Pharmaceuticals U.S.A., Inc.
$33,215
AbbVie Inc.
$30,407
ABBVIE INC.
$19,772
Seagen Inc.
$17,461
ADC Therapeutics America, Inc.
$16,705
Kite Pharma, Inc.
$15,596
Seattle Genetics, Inc.
$14,757
Astellas Pharma US Inc
$13,971
Genmab U.S., Inc.
$12,557
Epizyme, Inc.,
$11,766
Blueprint Medicines Corporation
$9,311
Amgen Inc.
$8,476
Aurobindo Pharma USA, Inc.
$8,035
AstraZeneca UK Limited
$6,377
Acrotech Biopharma LLC
$6,309
Ipsen Biopharmaceuticals, Inc
$4,540
Janssen Biotech, Inc.
$4,412
Stemline Therapeutics Inc.
$3,898
MorphoSys, US Inc.
$3,583
SOBI, INC
$3,302
Pharmacyclics LLC, An AbbVie Company
$3,105
Pharmacyclics LLC, an AbbVie Company
$2,876
GlaxoSmithKline, LLC.
$2,127
Verastem, Inc.
$1,680
CTI BioPharma Corp.
$1,620
Agios Pharmaceuticals, Inc.
$1,617
Genentech, Inc.
$1,589
Janssen Scientific Affairs, LLC
$1,515
Novartis Pharmaceuticals Corporation
$1,261
Merck Sharp & Dohme Corporation
$1,005
Teva Pharmaceuticals USA, Inc.
$870
PFIZER INC.
$627
Eli Lilly and Company
$500
TG THERAPEUTICS, INC.
$450
Karyopharm Therapeutics Inc.
$419
Clovis Oncology, Inc.
$361
Foundation Medicine, Inc.
$330
Exelixis Inc.
$258
Alexion Pharmaceuticals, Inc.
$258
Eisai Inc.
$257
PharmaEssentia USA Corporation
$245
GENZYME CORPORATION
$216
Rigel Pharmaceuticals, Inc.
$209
Boehringer Ingelheim Pharmaceuticals, Inc.
$198
Regeneron Healthcare Solutions, Inc.
$184
Stryker Corporation
$150
Daiichi Sankyo Inc.
$127
ARRAY BIOPHARMA INC
$116
TerSera Therapeutics LLC
$115
Coherus Biosciences Inc.
$114
PUMA BIOTECHNOLOGY, INC.
$101
Puma Biotechnology, Inc.
$89
EUSA Pharma (US) LLC
$88
G1 Therapeutics, Inc.
$82
Otsuka America Pharmaceutical, Inc.
$82
Deciphera Pharmaceuticals Inc.
$81
Dova Pharmaceuticals
$77
Bayer HealthCare Pharmaceuticals Inc.
$76
AMAG Pharmaceuticals, Inc.
$75
MEDIVATION FIELD SOLUTIONS LLC
$70
Merck Sharp & Dohme LLC
$61
Secura Bio, Inc.
$60
Taiho Oncology, Inc.
$59
TAIHO ONCOLOGY, INC.
$58
SERVIER PHARMACEUTICALS LLC
$57
Lexicon Pharmaceuticals, Inc.
$56
Immunocore Limited
$54
Spectrum Pharmaceuticals Inc.
$53
Sun Pharmaceutical Industries Inc.
$52
EISAI INC.
$51
EMD Serono, Inc.
$45
INSYS Therapeutics Inc
$43
Janssen Pharmaceuticals, Inc
$42
Bayer Healthcare Pharmaceuticals Inc.
$42
Helsinn Therapeutics (U.S.), Inc.
$36
Jazz Pharmaceuticals Inc.
$36
Mirati Therapeutics, Inc.
$28
Geron Corporation
$26
Dendreon Pharmaceuticals LLC
$26
AVEO Pharmaceuticals, Inc.
$24
CSL Behring
$23
ACCORD HEALTHCARE, INC.
$21
Adaptive Biotechnologies Corporation
$20
Mylan Pharmaceuticals Inc.
$20
Partner Therapeutics, Inc.
$20
Tempus AI, Inc
$20
TESARO, Inc.
$18
Advanced Accelerator Applications
$17
Kyowa Kirin, Inc.
$16
Sumitomo Pharma America, Inc.
$15
Sirtex Medical Inc
$15
Top 3 companies account for 37.5% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BELEODAQ · BENDEKA · BENLYSTA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Beleodaq · Blincyto · CABOMETYX · CALQUENCE · CAMCEVI · CARVYKTI · COSELA · CREON · CYRAMZA · Cabometyx · Columvi · Copiktra · Cresemba · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · EMPLICITI · EPKINLY · ERBITUX · ERLEADA · Enhertu · Epkinly · Erleada · FARYDAK · FERAHEME · FOLOTYN · FOTIVDA · FOUNDATIONONE · Fabhalta · Farydak · Folotyn · Fulphila · GAVRETO · GAZYVA · GILOTRIF · GRANIX · HEMLIBRA · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · IVS - VERTEBRAL AUGMENTATION PRODUCTS · Imbruvica · Inrebic · JADENU · JAKAFI · JAYPIRCA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Non-Covered Product · Nplate · Nubeqa · ODOMZO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POLIVY · PROMACTA · PROVENGE · PYRUKYND · Perjeta · Phesgo · Polivy · Pomalyst · Prolia · QINLOCK · REBLOZYL · RYBREVANT · RYDAPT · RYTELO · Revlimid · Rezlidhia · Rituxan · Rubraca · SANCUSO · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tazverik · Tecartus · Tibsovo · Truxima · Turalio · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vanflyta · Vectibix · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zydelig · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (85%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for hematology & oncology in CA.
Geographic Context
Hematology & oncology specialists within 10 mi
130
Per 100K population
4.0
County median income
$102,285
Nearest hospital
UC SAN DIEGO HEALTH HILLCREST - HILLCREST MED CTR
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Xavier is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Xavier experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Xavier performed 663 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Xavier receive payments from pharmaceutical companies?
Yes. Dr. Xavier received a total of $933,603 from 100 companies across 1,798 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Xavier's costs compare to other hematology & oncology specialists in San Diego?
Dr. Xavier's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Xavier) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in San Diego
Browse hematology & oncology specialists in San Diego ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology